NO994343L - Anvendelse av 2,3,4,5 - tetrahydro- 1H-3-benzazepiner for fremstilling av en farmasöytisk blanding for behandlingen av soveuregelmessigheter - Google Patents
Anvendelse av 2,3,4,5 - tetrahydro- 1H-3-benzazepiner for fremstilling av en farmasöytisk blanding for behandlingen av soveuregelmessigheterInfo
- Publication number
- NO994343L NO994343L NO994343A NO994343A NO994343L NO 994343 L NO994343 L NO 994343L NO 994343 A NO994343 A NO 994343A NO 994343 A NO994343 A NO 994343A NO 994343 L NO994343 L NO 994343L
- Authority
- NO
- Norway
- Prior art keywords
- bridge
- hydrogen
- treatment
- pharmaceutical composition
- sleep disorders
- Prior art date
Links
- 208000019116 sleep disease Diseases 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- MWVMYAWMFTVYED-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-3-benzazepine Chemical class C1CNCCC2=CC=CC=C21 MWVMYAWMFTVYED-UHFFFAOYSA-N 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical group 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 208000022925 sleep disturbance Diseases 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK26597 | 1997-03-12 | ||
| US4150997P | 1997-03-24 | 1997-03-24 | |
| PCT/DK1998/000088 WO1998040072A1 (en) | 1997-03-12 | 1998-03-11 | Use of 2,3,4,5-tetrahydro-1h-3-benzazepines for the manufacture of a pharmaceutical composition for the treatment of sleep disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO994343D0 NO994343D0 (no) | 1999-09-07 |
| NO994343L true NO994343L (no) | 1999-11-11 |
| NO324719B1 NO324719B1 (no) | 2007-12-03 |
Family
ID=26063641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19994343A NO324719B1 (no) | 1997-03-12 | 1999-09-07 | Anvendelse av 8-nitro-2,3,4,5-tetrahydro-1H-3-benzazepiner for fremstilling av en farmasoytisk sammensetning for behandling av soveuregelmessigheter |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6211173B1 (no) |
| EP (1) | EP1011679B1 (no) |
| JP (1) | JP2001515484A (no) |
| AT (1) | ATE245986T1 (no) |
| AU (1) | AU742873B2 (no) |
| BR (1) | BR9808234A (no) |
| CA (1) | CA2283083C (no) |
| CZ (1) | CZ296464B6 (no) |
| DE (1) | DE69816832T2 (no) |
| DK (1) | DK1011679T3 (no) |
| ES (1) | ES2203933T3 (no) |
| IL (1) | IL131670A (no) |
| NO (1) | NO324719B1 (no) |
| PL (1) | PL189822B1 (no) |
| PT (1) | PT1011679E (no) |
| WO (1) | WO1998040072A1 (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006526021A (ja) * | 2003-05-22 | 2006-11-16 | シェーリング コーポレイション | 肥満およびｃｎｓ障害を治療する選択的ｄ１／ｄ５レセプタアンタゴニストとしての５ｈ−ベンゾ［ｄ］ナフト［２，１−ｂ］アゼピン誘導体 |
| EP2343073A3 (en) * | 2003-12-11 | 2011-10-12 | Sepracor Inc. | Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression |
| US20050215521A1 (en) * | 2003-12-22 | 2005-09-29 | Karim Lalji | Modafinil combination therapy for improving sleep quality |
| EP1696959A2 (en) * | 2003-12-24 | 2006-09-06 | Sepracor, Inc. | Melatonin combination therapy for improving sleep quality |
| EP1742624B1 (en) * | 2004-02-18 | 2010-01-06 | Sepracor, Inc. | Dopamine-agonist combination therapy with sedatives for improving sleep quality |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK325188D0 (da) | 1988-06-15 | 1988-06-15 | Novo Industri As | Hidtil ukendte benzazepinderivater |
| US5470850A (en) | 1992-02-24 | 1995-11-28 | Novo Nordisk A/S | 2,3,4,5-tetrahydro-1H-3-benzazepines |
| DK26793D0 (da) | 1993-03-10 | 1993-03-10 | Novo Nordisk As | Benzofuranyl- eller dihydrobenzofuranyl-substituerede tricycliske benzazepiner, der anvendelse og fremstilling |
-
1998
- 1998-03-11 CZ CZ0317799A patent/CZ296464B6/cs not_active IP Right Cessation
- 1998-03-11 IL IL13167098A patent/IL131670A/xx not_active IP Right Cessation
- 1998-03-11 BR BR9808234-5A patent/BR9808234A/pt not_active Application Discontinuation
- 1998-03-11 US US09/380,840 patent/US6211173B1/en not_active Expired - Fee Related
- 1998-03-11 EP EP98907896A patent/EP1011679B1/en not_active Expired - Lifetime
- 1998-03-11 JP JP53910298A patent/JP2001515484A/ja not_active Ceased
- 1998-03-11 AU AU66100/98A patent/AU742873B2/en not_active Ceased
- 1998-03-11 PL PL98335545A patent/PL189822B1/pl not_active IP Right Cessation
- 1998-03-11 DK DK98907896T patent/DK1011679T3/da active
- 1998-03-11 PT PT98907896T patent/PT1011679E/pt unknown
- 1998-03-11 ES ES98907896T patent/ES2203933T3/es not_active Expired - Lifetime
- 1998-03-11 AT AT98907896T patent/ATE245986T1/de active
- 1998-03-11 CA CA002283083A patent/CA2283083C/en not_active Expired - Fee Related
- 1998-03-11 WO PCT/DK1998/000088 patent/WO1998040072A1/en not_active Ceased
- 1998-03-11 DE DE69816832T patent/DE69816832T2/de not_active Expired - Lifetime
-
1999
- 1999-09-07 NO NO19994343A patent/NO324719B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IL131670A0 (en) | 2001-01-28 |
| DK1011679T3 (da) | 2003-11-24 |
| EP1011679B1 (en) | 2003-07-30 |
| ATE245986T1 (de) | 2003-08-15 |
| PL189822B1 (pl) | 2005-09-30 |
| EP1011679A1 (en) | 2000-06-28 |
| CA2283083C (en) | 2007-09-04 |
| DE69816832D1 (de) | 2003-09-04 |
| CZ317799A3 (cs) | 2000-03-15 |
| NO324719B1 (no) | 2007-12-03 |
| PT1011679E (pt) | 2003-12-31 |
| AU6610098A (en) | 1998-09-29 |
| DE69816832T2 (de) | 2004-05-27 |
| JP2001515484A (ja) | 2001-09-18 |
| CZ296464B6 (cs) | 2006-03-15 |
| BR9808234A (pt) | 2000-05-16 |
| US6211173B1 (en) | 2001-04-03 |
| WO1998040072A1 (en) | 1998-09-17 |
| IL131670A (en) | 2005-07-25 |
| PL335545A1 (en) | 2000-04-25 |
| ES2203933T3 (es) | 2004-04-16 |
| CA2283083A1 (en) | 1998-09-17 |
| NO994343D0 (no) | 1999-09-07 |
| AU742873B2 (en) | 2002-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9800718A (es) | Derivados de 2-(4-substituidos)-bencilamino-2-metil- propanamida. | |
| JO2321B1 (en) | 4-phenyl-pyridine derivatives | |
| AU4497293A (en) | Phenoxy- and phenoxyalkyl-piperidines as antiviral agents | |
| AU1367497A (en) | Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma | |
| DE69227088D1 (de) | Verwendung von 1-(aminoalkyl)-3-Quinoxalin-2-on Derivaten zur Herstellung von neuroprotektiven Mitteln | |
| AU2868689A (en) | Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia | |
| ID26622A (id) | Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide | |
| NO994343D0 (no) | Anvendelse av 2,3,4,5 - tetrahydro- 1H-3-benzazepiner for fremstilling av en farmasöytisk blanding for behandlingen av soveuregelmessigheter | |
| DE69402935D1 (de) | Substituierte arylalkylaminobenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel | |
| AU3386299A (en) | N-aryloxyethylamine derivatives for the treatment of depression | |
| UA66888C2 (uk) | 3-тетрагідропіридин-4-іл індоли, спосіб їх отримання та спосіб лікування психічних розладів | |
| SE9702716D0 (sv) | Substituted phenylazacycloalkanes in the treatment of cognitive disorders | |
| NO973340L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av fedme | |
| TR200001926T2 (tr) | Vasküler başağrılarına karşı lokal anesteziklerin yeni kullanımı | |
| NO973242L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for behandling eller profylakse av idiopatisk eller fysiologisk gynekomasti | |
| ATE158301T1 (de) | 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren | |
| DE69310353D1 (de) | 2,3,4,5-tetrahydro-1h-3-benzazepine und ihre pharmazeutisch verträglichen säureadditionssalze | |
| TR199801683A2 (xx) | Yeni �re t�revleri. | |
| DK0788472T3 (da) | Fremgangsmåde til fremstilling af 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalenderivater | |
| SE9603284D0 (sv) | New compounds | |
| PT1140919E (pt) | Novos derivados de ciclohexano 1,4-dissubstituido para o tratamento da depressao | |
| TW289019B (no) | ||
| PT1068199E (pt) | N-ariloxietil-indoli-alquilaminas para o tratamento da depressao | |
| MX9705390A (es) | Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales. | |
| MX9705379A (es) | Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |